Last reviewed · How we verify
Treatment of unresectable or metastatic colorectal cancer
Approved treatments
- Folfiri · Pfizer
Clinical guidelines
- FDA label — 1L|2L|3L+
Capecitabine is indicated for the treatment of patients with unresectable or metastatic colorectal cancer as a single agent or as a component of a combination chemotherapy regimen. - FDA label — 2L
Capecitabine is indicated for the treatment of patients with advanced or metastatic breast cancer as a single agent if an anthracycline- or taxane-containing chemotherapy is not indicated. - FDA label — 2L
Capecitabine is indicated for the treatment of patients with advanced or metastatic breast cancer in combination with docetaxel after disease progression on prior anthracycline-containing chemotherapy.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Treatment of unresectable or metastatic colorectal cancer patent landscape — cliff calendar, originator estates, attackable patents
- Treatment of unresectable or metastatic colorectal cancer treatment landscape brief
- Treatment of unresectable or metastatic colorectal cancer treatment updates RSS
Frequently asked questions about Treatment of unresectable or metastatic colorectal cancer
What drugs treat Treatment of unresectable or metastatic colorectal cancer?
Tracked treatments include Folfiri.
What is the treatment for Treatment of unresectable or metastatic colorectal cancer?
Standard treatment for Treatment of unresectable or metastatic colorectal cancer includes Folfiri. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Treatment of unresectable or metastatic colorectal cancer?
FDA label publishes guidelines for Treatment of unresectable or metastatic colorectal cancer. 3 guideline references tracked.
Related
- Treatment landscape: Treatment of unresectable or metastatic colorectal cancer patent cliff · Treatment of unresectable or metastatic colorectal cancer CI report
- Treatment: Folfiri · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing